Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-EN | Version v9-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-11-17 | 2022-11-16 |
| Drug Identification Number | 02204266 | 02204266 |
| Brand name | DEXAMETHASONE-OMEGA | DEXAMETHASONE-OMEGA |
| Common or Proper name | DEXAMETHASONE SODIUM PHOSPHATE INJECTION | DEXAMETHASONE SODIUM PHOSPHATE INJECTION |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | DEXAMETHASONE PHOSPHATE | DEXAMETHASONE PHOSPHATE |
| Strength(s) | 4MG | 4MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR | SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR |
| Packaging size | 10 x 1mL vial / fiole | 10 x 1mL vial / fiole |
| ATC code | H02AB | H02AB |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| Reason for shortage | Shortage of an inactive ingredient or component. | Shortage of an inactive ingredient or component. |
| Anticipated start date | ||
| Actual start date | 2022-08-31 | 2022-08-31 |
| Estimated end date | 2022-11-18 | 2022-11-18 |
| Actual end date | 2022-11-16 | 2022-11-16 |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |